Klimovsky Judith V 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Dec 20, 2018
Insider Transaction Report
Form 4
Klimovsky Judith V.
Director
Transactions
- Award
Stock Option (right to buy)
2018-12-20+12,500→ 12,500 totalExercise: $3.36Exp: 2028-12-19→ Common Stock (12,500 underlying) - Award
Stock Option (right to buy)
2018-12-20+50,000→ 50,000 totalExercise: $3.36Exp: 2028-12-19→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The stock option vests and becomes exercisable in 36 equal monthly installments over a three-year period beginning from December 20, 2018.
- [F2]The stock option vests and becomes exercisable in equal monthly installments until the date of the Company's 2019 annual meeting of stockholders.